899 related articles for article (PubMed ID: 27320935)
1. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
Yoshizaki A
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic roles of B lymphocytes in systemic sclerosis.
Yoshizaki A
Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
[TBL] [Abstract][Full Text] [Related]
3. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
Hasegawa M
J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
[TBL] [Abstract][Full Text] [Related]
4. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
[TBL] [Abstract][Full Text] [Related]
5. B cells in systemic sclerosis: a possible target for therapy.
Bosello S; De Luca G; Tolusso B; Lama G; Angelucci C; Sica G; Ferraccioli G
Autoimmun Rev; 2011 Aug; 10(10):624-30. PubMed ID: 21545850
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
Hasegawa M; Fujimoto M; Takehara K; Sato S
J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity in systemic sclerosis: current concepts.
Boin F; Rosen A
Curr Rheumatol Rep; 2007 May; 9(2):165-72. PubMed ID: 17502048
[TBL] [Abstract][Full Text] [Related]
8. B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
Yoshizaki A
J Dermatol; 2016 Jan; 43(1):39-45. PubMed ID: 26782005
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of B cells for rheumatic autoimmune diseases.
Engel P; Gómez-Puerta JA; Ramos-Casals M; Lozano F; Bosch X
Pharmacol Rev; 2011 Mar; 63(1):127-56. PubMed ID: 21245206
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
[TBL] [Abstract][Full Text] [Related]
11. Early inflammatory players in cutanous fibrosis.
Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
[TBL] [Abstract][Full Text] [Related]
12. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.
Hasegawa M; Hamaguchi Y; Yanaba K; Bouaziz JD; Uchida J; Fujimoto M; Matsushita T; Matsushita Y; Horikawa M; Komura K; Takehara K; Sato S; Tedder TF
Am J Pathol; 2006 Sep; 169(3):954-66. PubMed ID: 16936269
[TBL] [Abstract][Full Text] [Related]
13. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
14. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
Baert L; Manfroi B; Casez O; Sturm N; Huard B
J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of systemic sclerosis-current concept and emerging treatments.
Furue M; Mitoma C; Mitoma H; Tsuji G; Chiba T; Nakahara T; Uchi H; Kadono T
Immunol Res; 2017 Aug; 65(4):790-797. PubMed ID: 28488090
[TBL] [Abstract][Full Text] [Related]
16. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
Hasegawa M; Takehara K
Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
[TBL] [Abstract][Full Text] [Related]
17. [B lymphocyte abnormalities in connective tissue disorders].
Sato S
Nihon Rinsho; 2009 Mar; 67(3):477-81. PubMed ID: 19280919
[TBL] [Abstract][Full Text] [Related]
18. A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.
van Dam LS; Osmani Z; Kamerling SWA; Kraaij T; Bakker JA; Scherer HU; Rabelink TJ; Voll RE; Alexander T; Isenberg DA; van Kooten C; Teng YKO
Rheumatology (Oxford); 2020 Oct; 59(10):2734-2745. PubMed ID: 31951278
[TBL] [Abstract][Full Text] [Related]
19. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
[TBL] [Abstract][Full Text] [Related]
20. B cells in multiple sclerosis therapy-A comprehensive review.
Rahmanzadeh R; Weber MS; Brück W; Navardi S; Sahraian MA
Acta Neurol Scand; 2018 Jun; 137(6):544-556. PubMed ID: 29512131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
